Whether Vaginal Microbiota Affects Pregnancy Outcomes After Embryo Transfer
1 other identifier
observational
161
1 country
1
Brief Summary
The goal of this observational study is to learn about vaginal microbial characteristics in the patients under in vitro fertilization treatment. The study aims to address the following questions: (1) Is there any difference in microbial composition between the pregnancy and non-pregnancy groups? (2) Is there any differences in specific bacterial species between the two groups? (3) What are the favorable or unfavorable profiles of vaginal microbiota associated with achieving pregnancy? Patients will be asked to complete a questionnaire regarding their basic characteristics, and vaginal secretions will be collected via vaginal swab during frozen-blastocyst transfer procedures. The study will compare vaginal microbiota between pregnant and non-pregnant patients to assess its potential influence on clinical outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2022
CompletedFirst Submitted
Initial submission to the registry
February 28, 2024
CompletedFirst Posted
Study publicly available on registry
March 6, 2024
CompletedMarch 8, 2024
March 1, 2024
1.6 years
February 28, 2024
March 7, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Rate of clinical pregnancy
Clinical pregnancy is defined as the presence of a gestational sac confirmed by transvaginal ultrasound examination.
4 weeks after embryo transfer for the patient
Eligibility Criteria
The patients who are under IVF treatment and have at least one high-quality euploid blastocysts to transfer. In addition, the participants should not have severe conditions that could adversely affect pregnancy outcomes, such as premature ovarian insufficiency or severe endometriosis.
You may qualify if:
- Woman of 20-40 years of age
- Woman who have regular menstrual cycles and normal level of E2, P, FSH, LH, T, RPL in the early follicular phase
- Women who are scheduled for PGT cycles in IVF center and have a euploid blastocyst to transfer
- Women who have normal uterine and adnexal ultrasonography
You may not qualify if:
- embryos underwent double vitrification or a second biopsy
- patients having premature ovarian insufficiency (FSH \> 12 mIU/ml and AMH \< 1.1 ng/ml), abnormal uterine cavity, systemic disease, endometriosis American Fertility Score III/IV, or cancer
- those testing positive for mold spores or trichomonas in vaginal secretion examination and subjectively reported abnormal vaginal symptoms such as vaginal itching at 7 days before embryo transfer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shanghai Ji Ai Genetics & IVF Institute
Shanghai, China
Related Publications (1)
Koedooder R, Singer M, Schoenmakers S, Savelkoul PHM, Morre SA, de Jonge JD, Poort L, Cuypers WJSS, Beckers NGM, Broekmans FJM, Cohlen BJ, den Hartog JE, Fleischer K, Lambalk CB, Smeenk JMJS, Budding AE, Laven JSE. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study. Hum Reprod. 2019 Jun 4;34(6):1042-1054. doi: 10.1093/humrep/dez065.
PMID: 31119299RESULT
Biospecimen
vaginal secretion
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yijuan Sun, Ph.D
ShangHai Ji Ai Genetics & IVF Institute
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 28, 2024
First Posted
March 6, 2024
Study Start
April 1, 2021
Primary Completion
October 30, 2022
Study Completion
October 30, 2022
Last Updated
March 8, 2024
Record last verified: 2024-03